Application of combination detection of CA15-3, CEA, COX-2 on diagnosis of breast carcinoma
10.3760/cma.j.issn.1006-9801.2013.01.014
- VernacularTitle:糖类抗原15-3、癌胚抗原、环氧合酶-2联合检测在乳腺癌诊断中的应用
- Author:
Benchuan LI
;
Meihua GAO
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Tumor maker;
Combined detection
- From:
Cancer Research and Clinic
2013;(1):44-46
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the value of combination detection of CA15-3,CEA,COX-2 on early diagnosis of breast carcinoma.Methods 68 breast cancer patients,61 benign breast disease patients and 68 healthies were selected.Serum levels of COX-2 were detected by ELISA technique,CA15-3 and CEA levels were detected by electroche-miluminescence technique.Results Serum levels of CA15-3,CEA,COX-2 in breast carcinoma group were (34.67±13.20) U/ml,(7.38±3.87) ng/ml,(43.25±10.87) ng/ml.Their levels were higher than those in benign breast disease group and healthy group,the differences were significant (P < 0.01).In combination detection,the sensitivity was 84.9 %,and accuracy was 91.2 %,which were higher than single tumor marker used in breast cancer diagnosis.Conclusion The combined detection of CA15-3,CEA,COX-2 could increase the diagnosis rate of breast carcinoma.